These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 6328728

  • 1. Trials of an inactivated equid herpesvirus 1 vaccine: challenge with a subtype 1 virus.
    Burrows R, Goodridge D, Denyer MS.
    Vet Rec; 1984 Apr 14; 114(15):369-74. PubMed ID: 6328728
    [Abstract] [Full Text] [Related]

  • 2. Viraemia and abortions are not prevented by two commercial equine herpesvirus-1 vaccines after experimental challenge of horses.
    Bürki F, Rossmanith W, Nowotny N, Pallan C, Möstl K, Lussy H.
    Vet Q; 1990 Apr 14; 12(2):80-6. PubMed ID: 2163560
    [Abstract] [Full Text] [Related]

  • 3. Trials of an inactivated equid herpesvirus 1 vaccine: challenge with a subtype 2 virus.
    Mumford JA, Bates J.
    Vet Rec; 1984 Apr 14; 114(15):375-81. PubMed ID: 6328729
    [Abstract] [Full Text] [Related]

  • 4. Derivation and characterisation of a live equid herpes virus-1 (EHV-1) vaccine to protect against abortion and respiratory disease due to EHV-1.
    Patel JR, Bateman H, Williams J, Didlick S.
    Vet Microbiol; 2003 Jan 02; 91(1):23-39. PubMed ID: 12441229
    [Abstract] [Full Text] [Related]

  • 5. Application of a chemically inactivated, adjuvanted vaccine to control abortigenic infection of mares by equine herpesvirus I.
    Bryans JT, Allen GP.
    Dev Biol Stand; 1982 Jan 02; 52():493-8. PubMed ID: 6299858
    [Abstract] [Full Text] [Related]

  • 6. Clinical and virological evaluation of the efficacy of an inactivated EHV1 and EHV4 whole virus vaccine (Duvaxyn EHV1,4). Vaccination/challenge experiments in foals and pregnant mares.
    Heldens JG, Hannant D, Cullinane AA, Prendergast MJ, Mumford JA, Nelly M, Kydd JH, Weststrate MW, van den Hoven R.
    Vaccine; 2001 Jul 20; 19(30):4307-17. PubMed ID: 11457558
    [Abstract] [Full Text] [Related]

  • 7. Serological responses and clinical outcome after vaccination of mares and foals with equine herpesvirus type 1 and 4 (EHV-1 and EHV-4) vaccines.
    Bresgen C, Lämmer M, Wagner B, Osterrieder N, Damiani AM.
    Vet Microbiol; 2012 Nov 09; 160(1-2):9-16. PubMed ID: 22633483
    [Abstract] [Full Text] [Related]

  • 8. Vaccines for EHV1 abortion.
    Mitchell D.
    Vet Rec; 1983 Mar 19; 112(12):285. PubMed ID: 6302971
    [No Abstract] [Full Text] [Related]

  • 9. Equine herpesvirus.
    Vet Rec; 1989 May 13; 124(19):519. PubMed ID: 2547266
    [No Abstract] [Full Text] [Related]

  • 10. Equine herpesvirus 1 infection in mares vaccinated with a live-virus rhinopneumonitis vaccine attenuated in cell culture.
    Eaglesome MD, Henry JN, McKnight JD.
    Can Vet J; 1979 May 13; 20(5):145-7. PubMed ID: 226261
    [Abstract] [Full Text] [Related]

  • 11. Vaccination of mares against equine herpesvirus-1.
    Pickles AC.
    Vet Rec; 1992 Feb 22; 130(8):167-8. PubMed ID: 1314446
    [No Abstract] [Full Text] [Related]

  • 12. [Preventative vaccination against EHV (equine herpesvirus) abortion].
    Becker W.
    Tierarztl Prax; 1988 Feb 22; 16(1):61-3. PubMed ID: 2835828
    [Abstract] [Full Text] [Related]

  • 13. Equid herpesvirus (EHV-1) live vaccine strain C147: efficacy against respiratory diseases following EHV types 1 and 4 challenges.
    Patel JR, Földi J, Bateman H, Williams J, Didlick S, Stark R.
    Vet Microbiol; 2003 Mar 20; 92(1-2):1-17. PubMed ID: 12488066
    [Abstract] [Full Text] [Related]

  • 14. Towards a vaccine against equine herpesvirus 1.
    Sabine M, Whalley JM.
    Aust Vet J; 1989 Dec 20; 66(12):403-4. PubMed ID: 2559691
    [No Abstract] [Full Text] [Related]

  • 15. Pre-infection frequencies of equine herpesvirus-1 specific, cytotoxic T lymphocytes correlate with protection against abortion following experimental infection of pregnant mares.
    Kydd JH, Wattrang E, Hannant D.
    Vet Immunol Immunopathol; 2003 Dec 15; 96(3-4):207-17. PubMed ID: 14592733
    [Abstract] [Full Text] [Related]

  • 16. Control of EHV-1 viremia and nasal shedding by commercial vaccines.
    Goehring LS, Wagner B, Bigbie R, Hussey SB, Rao S, Morley PS, Lunn DP.
    Vaccine; 2010 Jul 19; 28(32):5203-11. PubMed ID: 20538091
    [Abstract] [Full Text] [Related]

  • 17. Vaccination of pregnant ponies against equine rhinopneumonitis.
    Crandell RA, Mock RE, Lock TF.
    Am J Vet Res; 1980 Jul 19; 41(7):994-6. PubMed ID: 6254412
    [Abstract] [Full Text] [Related]

  • 18. Serological responses of mares and weanlings following vaccination with an inactivated whole virus equine herpesvirus 1 and equine herpesvirus 4 vaccine.
    Foote CE, Love DN, Gilkerson JR, Whalley JM.
    Vet Microbiol; 2002 Aug 02; 88(1):13-25. PubMed ID: 12119135
    [Abstract] [Full Text] [Related]

  • 19. Vaccination of foals and pregnant mares with Duvaxyn EHV1, 4 vaccine.
    Studdert MJ.
    Vaccine; 2002 Jan 15; 20(7-8):992. PubMed ID: 11803056
    [No Abstract] [Full Text] [Related]

  • 20. Intranasal IgG4/7 antibody responses protect horses against equid herpesvirus-1 (EHV-1) infection including nasal virus shedding and cell-associated viremia.
    Perkins G, Babasyan S, Stout AE, Freer H, Rollins A, Wimer CL, Wagner B.
    Virology; 2019 May 15; 531():219-232. PubMed ID: 30928700
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.